Smith named CEO at Remix 

Peter Smith, co-founder, president and CSO of RNA processing company  Remix Therapeutics Inc., has become CEO of the start-up while remaining president. Smith co-founded Remix with Atlas Venture’s Kevin Bitterman in 2019; the company has since raised $81 million from investors including Atlas, The Column Group, Foresite Capital, Arch Venture Partners, Casdin Capital and Alexandria Venture Investments.

“RNA processing is the act of fine-tuning RNA after it’s transcribed from DNA and core to determining its function even before it’s translated into a protein,” Smith told BioCentury when the company came out of stealth in December 2020...